Skip to main content

Closed

AURA: Aura Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-95.5%

Financially safe

Stretched

Debt / equity0.16×

Interest coverage0.0×

Current ratio7.09×

Aura Biosciences, Inc.

AURANASDAQ Global Market·USD·Closed

Aura Biosciences, Inc.

AURANASDAQ·USD·Closed

$7.01

−1.41%

$7.01

−$0.10 (1.41%)

52W Range

47thpctl

Volume

0.43×avg

Mkt Cap

450.04MUSD

P/E

-4.0TTM

Div Yield

–ann

52W Range

47thpctl

Volume

0.43×avg

Market Cap

450.04MUSD

P/E Ratio

-4.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings